IPAD-DB ID | C00655 |
Name | Rhapontigenin |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 1 4 O 4 |
Molecular Weight | 258.269g/mol |
IUPAC Name | 5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]benzene-1, 3-diol |
InChI | InChI=1S/C15H14O4/c1-19-15-5-4-10(8-14(15)18)2-3-11-6-12(16)9-13(17)7-11/h2-9, 16-18H, 1H3/b3-2+ |
InChIKey | PHMHDRYYFAYWEG-NSCUHMNNSA-N |
Canonical SMILES | COC1=C(C=C(C=C1)C=CC2=CC(=CC(=C2)O)O)O |
PubChem CID | 5320954 |
DrugBank Accession Number | - |
CAS Registry Number | 500-65-2 |
Molecular Weight(Computed by SwissADME) | 258.27 |
Hac(Computed by SwissADME) | 19 |
Volume(Computed by ADMETlab 2.0) | 267.589 |
Density(Computed by ADMETlab 2.0) | 0.965 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 13 |
Flexibility(Computed by ADMETlab 2.0) | 0.231 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -2.574 |
LogD(Computed by ADMETlab 2.0) | 3.358 |
logP(Computed by ADMETlab 2.0) | 2.9 |
TPSA(Computed by SwissADME) | 69.92 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 3 |
Rotatable Bonds(Computed by SwissADME) | 3 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.33 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |